Gene therapy for human liver diseases

Cristiana Di Campli, Jian Wu, Antonio Gasbarrini, Giovanni Gasbarrini, Mark A Zern

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The liver can be considered an ideal target to design gene therapy strategies because of the unique properties of hepatic cells. The great amount of work carried out in this field clearly delineates the quality of the new approaches that have been developed in the last few years and demonstrates the feasibility of this strategy in a wide range of multi-factorial and inherited disorders. However, improvement of current vectors to specifically and efficiently deliver the therapeutic gene into the target cell remains a daunting problem. In this review, we will summarize the most important approaches that are currently under investigation, the pathological conditions that can be treated by this strategy and the most important drawbacks that remain to be overcome in order to achieve long-term and high-level gene expression.

Original languageEnglish (US)
Pages (from-to)421-429
Number of pages9
JournalEuropean Journal of Gastroenterology and Hepatology
Volume11
Issue number4
StatePublished - 1999
Externally publishedYes

Fingerprint

Genetic Therapy
Liver Diseases
Hepatocytes
Gene Expression
Liver
Genes
Therapeutics

Keywords

  • Gene therapy
  • Liposomes
  • Liver diseases
  • Viral vectors

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Di Campli, C., Wu, J., Gasbarrini, A., Gasbarrini, G., & Zern, M. A. (1999). Gene therapy for human liver diseases. European Journal of Gastroenterology and Hepatology, 11(4), 421-429.

Gene therapy for human liver diseases. / Di Campli, Cristiana; Wu, Jian; Gasbarrini, Antonio; Gasbarrini, Giovanni; Zern, Mark A.

In: European Journal of Gastroenterology and Hepatology, Vol. 11, No. 4, 1999, p. 421-429.

Research output: Contribution to journalArticle

Di Campli, C, Wu, J, Gasbarrini, A, Gasbarrini, G & Zern, MA 1999, 'Gene therapy for human liver diseases', European Journal of Gastroenterology and Hepatology, vol. 11, no. 4, pp. 421-429.
Di Campli C, Wu J, Gasbarrini A, Gasbarrini G, Zern MA. Gene therapy for human liver diseases. European Journal of Gastroenterology and Hepatology. 1999;11(4):421-429.
Di Campli, Cristiana ; Wu, Jian ; Gasbarrini, Antonio ; Gasbarrini, Giovanni ; Zern, Mark A. / Gene therapy for human liver diseases. In: European Journal of Gastroenterology and Hepatology. 1999 ; Vol. 11, No. 4. pp. 421-429.
@article{e588dc8cb15e4c8490bfc62d85dba0c0,
title = "Gene therapy for human liver diseases",
abstract = "The liver can be considered an ideal target to design gene therapy strategies because of the unique properties of hepatic cells. The great amount of work carried out in this field clearly delineates the quality of the new approaches that have been developed in the last few years and demonstrates the feasibility of this strategy in a wide range of multi-factorial and inherited disorders. However, improvement of current vectors to specifically and efficiently deliver the therapeutic gene into the target cell remains a daunting problem. In this review, we will summarize the most important approaches that are currently under investigation, the pathological conditions that can be treated by this strategy and the most important drawbacks that remain to be overcome in order to achieve long-term and high-level gene expression.",
keywords = "Gene therapy, Liposomes, Liver diseases, Viral vectors",
author = "{Di Campli}, Cristiana and Jian Wu and Antonio Gasbarrini and Giovanni Gasbarrini and Zern, {Mark A}",
year = "1999",
language = "English (US)",
volume = "11",
pages = "421--429",
journal = "European Journal of Gastroenterology and Hepatology",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Gene therapy for human liver diseases

AU - Di Campli, Cristiana

AU - Wu, Jian

AU - Gasbarrini, Antonio

AU - Gasbarrini, Giovanni

AU - Zern, Mark A

PY - 1999

Y1 - 1999

N2 - The liver can be considered an ideal target to design gene therapy strategies because of the unique properties of hepatic cells. The great amount of work carried out in this field clearly delineates the quality of the new approaches that have been developed in the last few years and demonstrates the feasibility of this strategy in a wide range of multi-factorial and inherited disorders. However, improvement of current vectors to specifically and efficiently deliver the therapeutic gene into the target cell remains a daunting problem. In this review, we will summarize the most important approaches that are currently under investigation, the pathological conditions that can be treated by this strategy and the most important drawbacks that remain to be overcome in order to achieve long-term and high-level gene expression.

AB - The liver can be considered an ideal target to design gene therapy strategies because of the unique properties of hepatic cells. The great amount of work carried out in this field clearly delineates the quality of the new approaches that have been developed in the last few years and demonstrates the feasibility of this strategy in a wide range of multi-factorial and inherited disorders. However, improvement of current vectors to specifically and efficiently deliver the therapeutic gene into the target cell remains a daunting problem. In this review, we will summarize the most important approaches that are currently under investigation, the pathological conditions that can be treated by this strategy and the most important drawbacks that remain to be overcome in order to achieve long-term and high-level gene expression.

KW - Gene therapy

KW - Liposomes

KW - Liver diseases

KW - Viral vectors

UR - http://www.scopus.com/inward/record.url?scp=0032922701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032922701&partnerID=8YFLogxK

M3 - Article

C2 - 10321760

AN - SCOPUS:0032922701

VL - 11

SP - 421

EP - 429

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

SN - 0954-691X

IS - 4

ER -